Insider Transactions in Q2 2021 at Intra Cellular Therapies, Inc. (ITCI)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Richard A Lerner Director |
BUY
Grant, award, or other acquisition
|
Indirect |
367
+0.38%
|
$14,680
$40.82 P/Share
|
|
Jun 30
2021
|
Rory B Riggs |
BUY
Grant, award, or other acquisition
|
Direct |
385
+0.5%
|
$15,400
$40.82 P/Share
|
|
Jun 30
2021
|
Robert L Van Nostrand |
BUY
Grant, award, or other acquisition
|
Direct |
173
+2.01%
|
$6,920
$40.82 P/Share
|
|
Jun 14
2021
|
Joel S Marcus |
SELL
Open market or private sale
|
Indirect |
18,289
-27.19%
|
$768,138
$42.27 P/Share
|
|
Jun 14
2021
|
Joel S Marcus |
BUY
Exercise of conversion of derivative security
|
Indirect |
20,000
+22.92%
|
$760,000
$38.35 P/Share
|
|
May 28
2021
|
Christopher D Alafi Director |
SELL
Open market or private sale
|
Indirect |
38,843
-29.02%
|
$1,553,720
$40.12 P/Share
|
|
May 27
2021
|
Joel S Marcus |
BUY
Exercise of conversion of derivative security
|
Direct |
13,767
+50.0%
|
-
|
|
May 27
2021
|
Rory B Riggs |
BUY
Exercise of conversion of derivative security
|
Direct |
13,767
+15.39%
|
-
|
|
May 27
2021
|
Christopher D Alafi Director |
SELL
Open market or private sale
|
Indirect |
8,482
-5.96%
|
$339,280
$40.01 P/Share
|
|
May 24
2021
|
Christopher D Alafi Director |
SELL
Open market or private sale
|
Indirect |
26,575
-15.73%
|
$1,063,000
$40.47 P/Share
|
|
May 21
2021
|
Christopher D Alafi Director |
SELL
Open market or private sale
|
Indirect |
1,100
-0.65%
|
$44,000
$40.0 P/Share
|
|
Apr 12
2021
|
Joel S Marcus |
SELL
Bona fide gift
|
Indirect |
25,000
-34.59%
|
-
|